Award
Purchase Order #75F40126P00176
FDA Terminates Cyprotex Scientific Services Purchase Order
Buyer
Food and Drug Administration
Award Amount
$70,500.00
Ceiling
$70,500.00
Period of Performance
Sep 01, 2026 – Oct 09, 2026
Identifier
75F40126P00176
NAICS
541690
This purchase-order modification terminates, for the government’s convenience, an order with Cyprotex US LLC, a provider of laboratory testing and bioanalytical services used in pharmaceutical research. The original order was intended to provide specialized scientific support for government research, but the available record does not specify the tests, deliverables, or reason for termination. The modification ends the planned work; it does not establish that services were completed. Its effect is to change the agency’s planned research support, though broader implications are not stated. The record does not identify whether the order was competitively awarded or sole-source, or provide a contract vehicle, acquisition program, subcontractors, prior related contracts, or original solicitation details. Performance was planned as a brief engagement in Framingham, Massachusetts, and the order was recently modified to terminate.
Description
THE PURPOSE OF THIS MODIFICATION IS TO TERMINATE OF THE CONTRACT FOR CONVENIENCE OF THE GOVERNMENT.